Apotex   Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Toronto Canada (1974)
Status: No NME R&D (1974)

Organization Overview

First Clinical Trial
2004
NCT00103753
First Marketed Drug
1974
melphalan (alkeran)
First NDA Approval
1992
paroxetine (paxil)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

APOTEX | APOTEX CORP | Apotex Inc. | APOTEX INC | APOTEX TECHNOLOGIES